Detail Information of Post-Translational Modifications
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0186 Transporter Info | ||||
Gene Name | SLC25A25 | ||||
Transporter Name | Calcium-binding mitochondrial carrier protein SCaMC-2 | ||||
Gene ID | |||||
UniProt ID | |||||
Post-Translational Modification of This DT | |||||
Overview of SLC25A25 Modification Sites with Functional and Structural Information | |||||
Sequence |
MLCLCLYVPV IGEAQTEFQY FESKGLPAEL KSIFKLSVFI PSQEFSTYRQ WKQKIVQAGD
KDLDGQLDFE EFVHYLQDHE KKLRLVFKSL DKKNDGRIDA QEIMQSLRDL GVKISEQQAE KILKSMDKNG TMTIDWNEWR DYHLLHPVEN IPEIILYWKH STIFDVGENL TVPDEFTVEE RQTGMWWRHL VAGGGAGAVS RTCTAPLDRL KVLMQVHASR SNNMGIVGGF TQMIREGGAR SLWRGNGINV LKIAPESAIK FMAYEQIKRL VGSDQETLRI HERLVAGSLA GAIAQSSIYP MEVLKTRMAL RKTGQYSGML DCARRILARE GVAAFYKGYV PNMLGIIPYA GIDLAVYETL KNAWLQHYAV NSADPGVFVL LACGTMSSTC GQLASYPLAL VRTRMQAQAS IEGAPEVTMS SLFKHILRTE GAFGLYRGLA PNFMKVIPAV SISYVVYENL KITLGVQSR |
||||
PTM type |
X-Oxidation
X-Phosphorylation
X-Ubiquitination
X: Amino Acid
|
Oxidation |
|||||
---|---|---|---|---|---|
Cystine |
2 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A25 | [1] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Cystine |
Modified Location |
203 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Oxidation at SLC25A25 Cystine 203 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC25A25 | [1] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Cystine |
Modified Location |
322 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Oxidation at SLC25A25 Cystine 322 has the potential to affect its expression or activity. | ||||
Phosphorylation |
|||||
Serine |
6 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A25 | [2] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
32 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A25 Serine 32 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC25A25 | [3] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
200 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A25 Serine 200 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 3 |
Have the potential to influence SLC25A25 | [2] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
241 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A25 Serine 241 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 4 |
Have the potential to influence SLC25A25 | [4] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
372 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A25 Serine 372 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 5 |
Have the potential to influence SLC25A25 | [4] , [5] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
395 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A25 Serine 395 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 6 |
Have the potential to influence SLC25A25 | [2] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
421 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A25 Serine 421 has the potential to affect its expression or activity. | ||||
Tyrosine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A25 | [4] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Tyrosine |
Modified Location |
396 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A25 Tyrosine 396 has the potential to affect its expression or activity. | ||||
Ubiquitination |
|||||
Alanine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A25 | [6] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Alanine |
Modified Location |
286 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Alanine 286 has the potential to affect its expression or activity. | ||||
Arginine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A25 | [7] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Arginine |
Modified Location |
325 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Arginine 325 has the potential to affect its expression or activity. | ||||
Asparticacid |
2 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A25 | [8] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Asparticacid |
Modified Location |
141 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Asparticacid 141 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC25A25 | [7] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Asparticacid |
Modified Location |
165 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Asparticacid 165 has the potential to affect its expression or activity. | ||||
Glutamicacid |
2 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A25 | [6] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Glutamicacid |
Modified Location |
149 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Glutamicacid 149 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC25A25 | [7] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Glutamicacid |
Modified Location |
302 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Glutamicacid 302 has the potential to affect its expression or activity. | ||||
Glutamine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A25 | [8] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Glutamine |
Modified Location |
101 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Glutamine 101 has the potential to affect its expression or activity. | ||||
Glycine |
3 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A25 | [6] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Glycine |
Modified Location |
272 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Glycine 272 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC25A25 | [7] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Glycine |
Modified Location |
314 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Glycine 314 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 3 |
Have the potential to influence SLC25A25 | [7] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Glycine |
Modified Location |
351 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Glycine 351 has the potential to affect its expression or activity. | ||||
Isoleucine |
3 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A25 | [8] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Isoleucine |
Modified Location |
155 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Isoleucine 155 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC25A25 | [7] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Isoleucine |
Modified Location |
280 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Isoleucine 280 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 3 |
Have the potential to influence SLC25A25 | [6] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Isoleucine |
Modified Location |
298 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Isoleucine 298 has the potential to affect its expression or activity. | ||||
Leucine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A25 | [6] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Leucine |
Modified Location |
284 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Leucine 284 has the potential to affect its expression or activity. | ||||
Lysine |
10 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A25 | [8] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
54 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Lysine 54 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC25A25 | [8] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
61 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Lysine 61 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 3 |
Have the potential to influence SLC25A25 | [8] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
81 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Lysine 81 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 4 |
Have the potential to influence SLC25A25 | [9] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
92 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Lysine 92 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 5 |
Have the potential to influence SLC25A25 | [10] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
113 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Lysine 113 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 6 |
Have the potential to influence SLC25A25 | [10] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
121 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Lysine 121 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 7 |
Have the potential to influence SLC25A25 | [10] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
252 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Lysine 252 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 8 |
Have the potential to influence SLC25A25 | [10] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
268 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Lysine 268 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 9 |
Have the potential to influence SLC25A25 | [10] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
305 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Lysine 305 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 10 |
Have the potential to influence SLC25A25 | [7] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
337 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Lysine 337 has the potential to affect its expression or activity. | ||||
Methionine |
2 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A25 | [9] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Methionine |
Modified Location |
126 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Methionine 126 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC25A25 | [7] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Methionine |
Modified Location |
214 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Methionine 214 has the potential to affect its expression or activity. | ||||
Proline |
2 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A25 | [7] , [8] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Proline |
Modified Location |
147 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Proline 147 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC25A25 | [7] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Proline |
Modified Location |
300 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Proline 300 has the potential to affect its expression or activity. | ||||
Serine |
4 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A25 | [8] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
115 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Serine 115 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC25A25 | [6] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
161 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Serine 161 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 3 |
Have the potential to influence SLC25A25 | [7] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
288 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Serine 288 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 4 |
Have the potential to influence SLC25A25 | [7] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
317 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Serine 317 has the potential to affect its expression or activity. | ||||
Threonine |
3 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A25 | [7] , [8] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
133 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Threonine 133 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC25A25 | [7] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
177 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Threonine 177 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 3 |
Have the potential to influence SLC25A25 | [7] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
202 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Threonine 202 has the potential to affect its expression or activity. | ||||
Tyrosine |
2 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A25 | [6] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Tyrosine |
Modified Location |
264 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Tyrosine 264 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC25A25 | [7] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Tyrosine |
Modified Location |
339 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Tyrosine 339 has the potential to affect its expression or activity. | ||||
Valine |
2 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A25 | [7] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Valine |
Modified Location |
10 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Valine 10 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC25A25 | [9] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Valine |
Modified Location |
112 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A25 Valine 112 has the potential to affect its expression or activity. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.